• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钇-90微球放射性栓塞成功治疗前列腺癌肝转移

Successful Yttrium-90 Microsphere Radioembolization for Hepatic Metastases of Prostate Cancer.

作者信息

Bunck Alexander C, Dos Santos Daniel Pinto, Chang De-Hua, Reiser Marcel, Pfister David, Bunck Anne, Drzezga Alexander, Maintz David, Schmidt Matthias

机构信息

Department of Radiology, University Hospital of Cologne, Cologne, Germany.

Practice for Oncology and Hematology, Cologne, Germany.

出版信息

Case Rep Oncol. 2017 Jul 11;10(2):627-633. doi: 10.1159/000478004. eCollection 2017 May-Aug.

DOI:10.1159/000478004
PMID:28868022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5566710/
Abstract

Prostate cancer is the most common solid tumor malignancy worldwide with an estimated 180,000 new cases of prostate cancer and 26,000 deaths in the USA in 2016. Although significant advances in the treatment of prostate cancer have recently been made, the treatment of metastatic disease remains a challenge. With visceral metastases marking more advanced tumor stages, liver involvement is associated with the worst prognosis. So far, no locoregional treatment regimens for the management of liver metastases of prostatic cancer exist. Herein, we report for the first time a successful treatment of hepatic metastases of prostatic cancer using radioembolization with selective intra-arterial administration of Yttrium-90 resin microspheres.

摘要

前列腺癌是全球最常见的实体瘤恶性肿瘤,2016年美国估计有18万例新的前列腺癌病例和2.6万例死亡。尽管近年来前列腺癌的治疗取得了重大进展,但转移性疾病的治疗仍然是一个挑战。内脏转移标志着肿瘤分期更晚,肝脏受累与最差的预后相关。到目前为止,尚无用于治疗前列腺癌肝转移的局部区域治疗方案。在此,我们首次报告了使用钇-90树脂微球选择性动脉内给药进行放射性栓塞成功治疗前列腺癌肝转移的病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d78f/5566710/abc4682d8934/cro-0010-0627-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d78f/5566710/7fec54f14b5c/cro-0010-0627-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d78f/5566710/5ca43532bfec/cro-0010-0627-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d78f/5566710/336e7a32d649/cro-0010-0627-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d78f/5566710/abc4682d8934/cro-0010-0627-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d78f/5566710/7fec54f14b5c/cro-0010-0627-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d78f/5566710/5ca43532bfec/cro-0010-0627-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d78f/5566710/336e7a32d649/cro-0010-0627-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d78f/5566710/abc4682d8934/cro-0010-0627-g04.jpg

相似文献

1
Successful Yttrium-90 Microsphere Radioembolization for Hepatic Metastases of Prostate Cancer.钇-90微球放射性栓塞成功治疗前列腺癌肝转移
Case Rep Oncol. 2017 Jul 11;10(2):627-633. doi: 10.1159/000478004. eCollection 2017 May-Aug.
2
Yttrium-90 microsphere radioembolization for treatment of lung cancer hepatic metastases.钇-90微球放射性栓塞治疗肺癌肝转移
Case Rep Oncol. 2012 May;5(2):479-86. doi: 10.1159/000342706. Epub 2012 Aug 30.
3
Yttrium-90 radioembolization of hepatic metastases from colorectal cancer.结直肠癌肝转移的钇-90 放射性栓塞治疗。
Front Oncol. 2014 Jul 25;4:120. doi: 10.3389/fonc.2014.00120. eCollection 2014.
4
Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors.钇-90 选择性内照射治疗对非传统肝脏肿瘤的影响。
World J Gastroenterol. 2015 Jul 21;21(27):8271-83. doi: 10.3748/wjg.v21.i27.8271.
5
Yttrium-90 radioembolization of isolated hepatic adrenocortical carcinoma metastases with negative surgical pathology.手术病理结果为阴性的孤立性肝肾上腺皮质癌转移灶的钇-90放射性栓塞治疗
EJNMMI Res. 2021 Feb 18;11(1):17. doi: 10.1186/s13550-021-00755-0.
6
Safe and Successful Yttrium-90 Resin Microsphere Radioembolization in a Heavily Pretreated Patient with Chemorefractory Colorectal Liver Metastases after Biliary Stent Placement above the Papilla.在一名经多次治疗且在乳头上方放置胆管支架后出现化疗难治性结直肠癌肝转移的患者中,成功进行安全的钇-90树脂微球放射性栓塞治疗。
Case Reports Hepatol. 2014;2014:921406. doi: 10.1155/2014/921406. Epub 2014 Dec 17.
7
Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes.结直肠癌肝转移的放射性栓塞:适应证、技术及疗效
J Nucl Med. 2017 Sep;58(Suppl 2):104S-111S. doi: 10.2967/jnumed.116.187229.
8
Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy.比较单独延长静脉氟尿嘧啶输注与钇-90 树脂微球放射性栓塞治疗标准化疗耐药的肝转移结直肠癌的 III 期临床试验。
J Clin Oncol. 2010 Aug 10;28(23):3687-94. doi: 10.1200/JCO.2010.28.5643. Epub 2010 Jun 21.
9
Serious hepatic complications of selective internal radiation therapy with yttrium-90 microsphere radioembolization for unresectable liver tumors.钇-90微球放射性栓塞选择性内放射治疗不可切除肝肿瘤的严重肝脏并发症。
Asia Pac J Clin Oncol. 2014 Sep;10(3):266-72. doi: 10.1111/ajco.12229.
10
Insights into the Dose-Response Relationship of Radioembolization with Resin 90Y-Microspheres: A Prospective Cohort Study in Patients with Colorectal Cancer Liver Metastases.树脂90Y微球放射性栓塞剂量反应关系的见解:一项针对结直肠癌肝转移患者的前瞻性队列研究。
J Nucl Med. 2016 Jul;57(7):1014-9. doi: 10.2967/jnumed.115.166942. Epub 2016 Feb 23.

引用本文的文献

1
Successful radiofrequency ablation of liver metastases from prostate cancer.前列腺癌肝转移灶的成功射频消融
IJU Case Rep. 2022 Aug 5;5(6):455-458. doi: 10.1002/iju5.12513. eCollection 2022 Nov.
2
Second line chemotherapy and visceral metastases are associated with poor survival in patients with mCRPC receiving Lu-PSMA-617.在接受 Lu-PSMA-617 治疗的 mCRPC 患者中,二线化疗和内脏转移与生存不良相关。
Theranostics. 2019 Jul 9;9(17):4841-4848. doi: 10.7150/thno.35759. eCollection 2019.

本文引用的文献

1
Changing face of metastatic prostate cancer: the law of diminishing returns holds true.转移性前列腺癌的面貌正在改变:收益递减规律依然适用。
Curr Opin Oncol. 2017 May;29(3):196-200. doi: 10.1097/CCO.0000000000000370.
2
Isolated Hepatic Metastasis from Prostate Carcinoma.前列腺癌孤立性肝转移
Urol Case Rep. 2016 Dec 6;10:51-53. doi: 10.1016/j.eucr.2016.11.012. eCollection 2017 Jan.
3
Successful Treatment of Hepatic Metastases of Hormone Refractory Prostate Cancer Using Radioligand Therapy With 177Lu-PSMA-617.使用 177Lu-PSMA-617 放射性配体疗法成功治疗激素难治性前列腺癌肝转移。
Clin Nucl Med. 2016 Nov;41(11):894-895. doi: 10.1097/RLU.0000000000001358.
4
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer.EAU-ESTRO-SIOG 前列腺癌诊治指南。第二部分:复发、转移和去势抵抗性前列腺癌的治疗。
Eur Urol. 2017 Apr;71(4):630-642. doi: 10.1016/j.eururo.2016.08.002. Epub 2016 Aug 31.
5
Increasing incidence of metastatic prostate cancer in the United States (2004-2013).美国转移性前列腺癌发病率的增加(2004-2013 年)。
Prostate Cancer Prostatic Dis. 2016 Dec;19(4):395-397. doi: 10.1038/pcan.2016.30. Epub 2016 Jul 19.
6
Predictors of Time to Metastasis in Castration-resistant Prostate Cancer.去势抵抗性前列腺癌转移时间的预测因素
Urology. 2016 Oct;96:171-176. doi: 10.1016/j.urology.2016.06.011. Epub 2016 Jun 16.
7
Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer.评估转移部位对去势抵抗性前列腺癌男性患者总生存期影响的Meta分析
J Clin Oncol. 2016 May 10;34(14):1652-9. doi: 10.1200/JCO.2015.65.7270. Epub 2016 Mar 7.
8
Mechanisms of resistance in castration-resistant prostate cancer (CRPC).去势抵抗性前列腺癌(CRPC)的耐药机制。
Transl Androl Urol. 2015 Jun;4(3):365-80. doi: 10.3978/j.issn.2223-4683.2015.05.02.
9
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer.转移性激素敏感性前列腺癌的化学激素疗法
N Engl J Med. 2015 Aug 20;373(8):737-46. doi: 10.1056/NEJMoa1503747. Epub 2015 Aug 5.
10
Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available Therapies.治疗转移性去势抵抗性前列腺癌患者:现有疗法的全面综述
J Urol. 2015 Dec;194(6):1537-47. doi: 10.1016/j.juro.2015.06.106. Epub 2015 Jul 18.